Mark A. Hardy

8.3k total citations
259 papers, 6.1k citations indexed

About

Mark A. Hardy is a scholar working on Surgery, Transplantation and Immunology. According to data from OpenAlex, Mark A. Hardy has authored 259 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Surgery, 71 papers in Transplantation and 57 papers in Immunology. Recurrent topics in Mark A. Hardy's work include Renal Transplantation Outcomes and Treatments (56 papers), Organ Transplantation Techniques and Outcomes (45 papers) and Transplantation: Methods and Outcomes (44 papers). Mark A. Hardy is often cited by papers focused on Renal Transplantation Outcomes and Treatments (56 papers), Organ Transplantation Techniques and Outcomes (45 papers) and Transplantation: Methods and Outcomes (44 papers). Mark A. Hardy collaborates with scholars based in United States, Canada and United Kingdom. Mark A. Hardy's co-authors include K Reemtsma, Soji F. Oluwole, Alan I. Benvenisty, Lloyd E. Ratner, Nicole Suciu‐Foca, Piotr Witkowski, David Woodland, Abbas Rana, Henry T. Lau and Karim J. Halazun and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Mark A. Hardy

251 papers receiving 5.9k citations

Peers

Countries citing papers authored by Mark A. Hardy

Since Specialization

Citations

This map shows the geographic impact of Mark A. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Hardy more than expected).

Fields of papers citing papers by Mark A. Hardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Hardy. The network helps show where Mark A. Hardy may publish in the future.

Co-authorship network of co-authors of Mark A. Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Hardy. A scholar is included among the top collaborators of Mark A. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Hardy. Mark A. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intradialytic Parenteral Nutrition during In-Center Hemodialysis of Patients Leads to Increase in Albumin without Compromising Safety 2025 ·Kidney360 ·(unknown), (unknown), (unknown), Mark A. Hardy, (unknown)	0
2	Loss of VSTM2A promotes adipocyte hypertrophy and disrupts metabolic homeostasis 2025 ·Obesity ·(unknown), Blandine Secco, (unknown), Michel Rochette, (unknown), (unknown), Mark A. Hardy, (unknown), William T. Festuccia, Mathieu C. Morissette, Venkata Manem, Mathieu Laplante	1
3	Spatiotemporal Clusters of Extracellular Signal-Regulated Kinase Activity Coordinate Cytokine-induced Inflammatory Responses in Human Airway Epithelial Cells 2024 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), (unknown), (unknown), Michael Pargett, (unknown), Devan Murphy, Mark A. Hardy, (unknown), Amir A. Zeki, John G. Albeck	3
4	RGDfK-Peptide Modified Alginate Scaffold for Cell Transplantation and Cardiac Neovascularization 2017 ·Tissue Engineering Part A ·Hugo Sondermeijer, Piotr Witkowski, Tetsunori Seki, Arnoud van der Laarse, Silviu Itescu, Mark A. Hardy	21
5	The immunologic considerations in human head transplantation 2017 ·International Journal of Surgery ·Mark A. Hardy, Allen Furr, Juan P. Barret, John H. Barker	6
6	Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study 2016 ·European Heart Journal ·Ziad A. Ali, Keyvan Karimi Galougahi, Tamim Nazif, Akiko Maehara, Mark A. Hardy, David J. Cohen, Lloyd E. Ratner, Michael Collins, Jeffrey W. Moses, Ajay J. Kirtane, Gregg W. Stone, Dimitri Karmpaliotis, Martin B. Leon	131
7	Mark M. Ravitch: Historian and Innovator 2010 ·Journal of surgical education ·Abbey Fingeret, (unknown), (unknown), Mark A. Hardy	0
8	Multicenter, Randomized Study of the Use of Everolimus With Tacrolimus After Renal Transplantation Demonstrates its Effectiveness 2008 ·Transplantation ·Laurence Chan, Stuart Greenstein, Mark A. Hardy, Erica Hartmann, Suphamai Bunnapradist, Diane M. Cibrik, Yi‐Ju Li, (unknown), Bettina Ulbricht, Matthew Cooper	95
9	Does Training Novices to Criteria and Does Rapid Acquisition of Skills on Laparoscopic Simulators Have Predictive Validity or Are We Just Playing Video Games? 2008 ·Journal of surgical education ·Nancy J. Hogle, Warren D. Widmann, (unknown), Mark A. Hardy, Dennis Fowler	47
10	Survival Outcomes Following Liver Transplantation (SOFT) Score: A Novel Method to Predict Patient Survival Following Liver Transplantation 2008 ·American Journal of Transplantation ·Abbas Rana, Mark A. Hardy, Karim J. Halazun, David Woodland, Lloyd E. Ratner, Benjamin Samstein, James V. Guarrera, Robert S. Brown, Jean C. Emond	326
11	Osmotic nephrosis in a renal transplant recipient 2006 ·Kidney International ·(unknown), David J. Cohen, Russell J. Crew, Mark A. Hardy, Lloyd E. Ratner, Vivette D. D’Agati, Glen S. Markowitz	12
12	Infectious tolerance mediated by CD8+ T-Suppresor Cells After UV-B–irradiated donor-specific transfusion and rat heart transplantation 2005 ·Transplantation Proceedings ·Piotr Witkowski, (unknown), (unknown), (unknown), Nicole Suciu‐Foca, Mark A. Hardy	3
13	Transplantation Diagnostics: A Preliminary Analysis Using Protein Microarray to Determine Kidney Status Prior To and Following Implantation 2004 ·John M. Baust, Aby J. Mathew, Kristi K. Snyder, (unknown), Robert G. Van Buskirk, Mark A. Hardy, (unknown)	2
14	Henri Albert Hartmann: Labor and discipline 2002 ·Current Surgery ·(unknown), Mark A. Hardy	15
15	A novel etiology of renal allograft dysfunction 2001 ·American Journal of Kidney Diseases ·Glen S. Markowitz, (unknown), Yuan Chang, Mark A. Hardy, Rola Saouaf, Vivette D. D’Agati	4
16	RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2 2000 ·Transplantation ·Christopher P. Johnson, Nasimul Ahsan, Thomas A. Gonwa, Philip F. Halloran, Mark D. Stegall, Mark A. Hardy, Robert A. Metzger, Charles F. Shield, Leslie Rocher, John D. Scandling, John B. Sorensen, Laura Mulloy, Jimmy A. Light, Claudia Corwin, Gabriel M. Danovitch, Michael Wachs, Paul VanVeldhuisen, (unknown), D. Tolzman, William E. Fitzsimmons	229
17	Restoration of immunogenicity of UVB-irradiated stimulator cells by the addition of lymphokines 1989 ·Soji F. Oluwole, Mark D. Stegall, (unknown), K Reemtsma, Mark A. Hardy	3
18	Long-term survival of islet allografts in spontaneously diabetic BB rats without chronic immunosuppression 1986 ·Transplantation Proceedings ·John A. Chabot, Hakwan Lau, K Reemtsma, Mark A. Hardy	8
19	Induction of indefinite rat islet allograft survival with direct ultraviolet irradiation and peritransplant cyclosporine 1985 ·Transplantation Proceedings ·Mark A. Hardy, K Reemtsma, Henry T. Lau	3
20	Effect of Selective Lymphoid Ablation on Rat Cardiac Allograft Survival 1979 ·European Surgical Research ·Mark A. Hardy, Rashid A. Fawwaz, Soji F. Oluwole, (unknown), Roman Nowygrod, K Reemtsma	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact